BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36633254)

  • 21. Phosphorylation of different tau sites during progression of Alzheimer's disease.
    Neddens J; Temmel M; Flunkert S; Kerschbaumer B; Hoeller C; Loeffler T; Niederkofler V; Daum G; Attems J; Hutter-Paier B
    Acta Neuropathol Commun; 2018 Jun; 6(1):52. PubMed ID: 29958544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain.
    Horie K; Barthélemy NR; Mallipeddi N; Li Y; Franklin EE; Perrin RJ; Bateman RJ; Sato C
    Acta Neuropathol Commun; 2020 Aug; 8(1):149. PubMed ID: 32854776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annexins A2 and A6 interact with the extreme N terminus of tau and thereby contribute to tau's axonal localization.
    Gauthier-Kemper A; Suárez Alonso M; Sündermann F; Niewidok B; Fernandez MP; Bakota L; Heinisch JJ; Brandt R
    J Biol Chem; 2018 May; 293(21):8065-8076. PubMed ID: 29636414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
    Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
    Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive blood biomarkers and brain changes associated with age-related cognitive decline.
    Saunders TS; Pozzolo FE; Heslegrave A; King D; McGeachan RI; Spires-Jones MP; Harris SE; Ritchie C; Muniz-Terrera G; Deary IJ; Cox SR; Zetterberg H; Spires-Jones TL
    Brain Commun; 2023; 5(3):fcad113. PubMed ID: 37180996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of PrP(C) Expression in Tau Protein Levels and Phosphorylation in Alzheimer's Disease Evolution.
    Vergara C; Ordóñez-Gutiérrez L; Wandosell F; Ferrer I; del Río JA; Gavín R
    Mol Neurobiol; 2015; 51(3):1206-20. PubMed ID: 24965601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STOX1A induces phosphorylation of tau proteins at epitopes hyperphosphorylated in Alzheimer's disease.
    van Abel D; Abdulhamid O; Scheper W; van Dijk M; Oudejans CB
    Neurosci Lett; 2012 Oct; 528(2):104-9. PubMed ID: 22995177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease.
    Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS
    J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and functional damage to neuronal nuclei caused by extracellular tau oligomers.
    Sun X; Eastman G; Shi Y; Saibaba S; Oliveira AK; Lukens JR; Norambuena A; Thompson JA; Purdy MD; Dryden K; Pardo E; Mandell JW; Bloom GS
    Alzheimers Dement; 2024 Mar; 20(3):1656-1670. PubMed ID: 38069673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines.
    Yu W; Polepalli J; Wagh D; Rajadas J; Malenka R; Lu B
    Hum Mol Genet; 2012 Mar; 21(6):1384-90. PubMed ID: 22156579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation of tau by fyn: implications for Alzheimer's disease.
    Lee G; Thangavel R; Sharma VM; Litersky JM; Bhaskar K; Fang SM; Do LH; Andreadis A; Van Hoesen G; Ksiezak-Reding H
    J Neurosci; 2004 Mar; 24(9):2304-12. PubMed ID: 14999081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly.
    Evans DB; Rank KB; Bhattacharya K; Thomsen DR; Gurney ME; Sharma SK
    J Biol Chem; 2000 Aug; 275(32):24977-83. PubMed ID: 10818091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
    Derkinderen P; Scales TM; Hanger DP; Leung KY; Byers HL; Ward MA; Lenz C; Price C; Bird IN; Perera T; Kellie S; Williamson R; Noble W; Van Etten RA; Leroy K; Brion JP; Reynolds CH; Anderton BH
    J Neurosci; 2005 Jul; 25(28):6584-93. PubMed ID: 16014719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease.
    Seward ME; Swanson E; Norambuena A; Reimann A; Cochran JN; Li R; Roberson ED; Bloom GS
    J Cell Sci; 2013 Mar; 126(Pt 5):1278-86. PubMed ID: 23345405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein.
    Eidenmüller J; Fath T; Maas T; Pool M; Sontag E; Brandt R
    Biochem J; 2001 Aug; 357(Pt 3):759-67. PubMed ID: 11463346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
    Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
    Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer's disease.
    Blazquez-Llorca L; Garcia-Marin V; Merino-Serrais P; Ávila J; DeFelipe J
    J Alzheimers Dis; 2011; 26(4):683-98. PubMed ID: 21677375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
    Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
    J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear Tau and Its Potential Role in Alzheimer's Disease.
    Bukar Maina M; Al-Hilaly YK; Serpell LC
    Biomolecules; 2016 Jan; 6(1):9. PubMed ID: 26751496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.